Historical Stock Price
ETFs Holding AGLE »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
08/04/2022 $0.41 $0.42 $0.40 $0.41 283.70K
08/05/2022 $0.43 $0.43 $0.41 $0.42 282.10K
08/08/2022 $0.44 $0.45 $0.42 $0.43 207.70K
08/09/2022 $0.42 $0.45 $0.40 $0.41 287.20K
08/10/2022 $0.42 $0.47 $0.41 $0.46 3.21M
Aeglea BioTherapeutics is a holding company. Through its subsidiaries, Co. is a biotechnology company developing human enzyme therapeutics for people with rare metabolic diseases. Co.'s development programs include: Pegzilarginase in Arginase 1 Deficiency, which is a recombinant human Arginase 1 that enzymatically degrades the amino acid arginine and improves the stability and arginine-degrading activity of the enzyme in human plasma; and AGLE-177 in Homocystinuria, which is a PEGylated, or polyethylene glycol modified, human enzyme engineered to degrade free homocysteine and homocystine. Co.'s preclinical pipeline includes cystinuria program to reduce plasma cystine and cysteine levels.
AGLE historical stock prices picture
Aeglea BioTherapeutics (AGLE) has the following price history information. Looking back at AGLE historical stock prices for the last five trading days, on August 04, 2022, AGLE opened at $0.41, traded as high as $0.42 and as low as $0.40, and closed at $0.41. Trading volume was a total of 283.70K shares. On August 05, 2022, AGLE opened at $0.43, traded as high as $0.43 and as low as $0.41, and closed at $0.42. Trading volume was a total of 282.10K shares. On August 08, 2022, AGLE opened at $0.44, traded as high as $0.45 and as low as $0.42, and closed at $0.43. Trading volume was a total of 207.70K shares. On August 09, 2022, AGLE opened at $0.42, traded as high as $0.45 and as low as $0.40, and closed at $0.41. Trading volume was a total of 287.20K shares. On August 10, 2022, AGLE opened at $0.42, traded as high as $0.47 and as low as $0.41, and closed at $0.46. Trading volume was a total of 3.21M shares.

AGLE Historical Stock Prices By Date:

AGLE historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aeglea BioTherapeutics shares, starting with a $10,000 purchase of AGLE, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/08/2016
End date: 08/10/2022
Start price/share: $11.99
End price/share: $0.46
Dividends collected/share: $0.00
Total return: -96.15%
Average Annual Total Return: -40.15%
Starting investment: $10,000.00
Ending investment: $385.51
Years: 6.34
Date Close
08/04/2022$0.41
08/05/2022$0.42
08/08/2022$0.43
08/09/2022$0.41
08/10/2022$0.46
AGLE is categorized under the Healthcare sector; below are some other companies in the same sector:

AGN Historical Stock Prices
AGRX Historical Stock Prices
AGTC Historical Stock Prices
AGTI Historical Stock Prices
AHCO Historical Stock Prices
AHPI Historical Stock Prices
AHS Historical Stock Prices
AIKI Historical Stock Prices
AIM Historical Stock Prices
AIMT Historical Stock Prices

Also explore: AGLE shares outstanding history

Email EnvelopeFree AGLE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

AGLE Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.